“Due to the size of our project area we have at least a decade of exploration ahead of us to grow production as the market grows.”Perhaps this is something that can be fast tracked with the help of GXY?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
